A Randomized, Open-Label, Four Period, Four-Treatment Crossover Study to Investigate the Comparative Bioavailability of Film-Coated Tablet and Granule Formulations of RG1662 Under Fed and Fasted Conditions in Healthy Volunteers

Trial Profile

A Randomized, Open-Label, Four Period, Four-Treatment Crossover Study to Investigate the Comparative Bioavailability of Film-Coated Tablet and Granule Formulations of RG1662 Under Fed and Fasted Conditions in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Sep 2015

At a glance

  • Drugs Basmisanil (Primary) ; Basmisanil
  • Indications Down syndrome
  • Focus Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 03 Nov 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 23 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top